2026年全球行動癌症篩檢設備市場報告

近年來，行動癌症篩檢設備的市場規模迅速擴張。預計該市場規模將從2025年的48.8億美元成長到2026年的55.4億美元，複合年成長率（CAGR）為13.5%。這一成長主要歸因於全球癌症發病率的上升、政府癌症防治宣傳活動的增加、對早期診斷項目需求的成長、醫療資源匱乏地區醫療服務可及性的改善以及醫療基礎設施投資的增加。

預計未來幾年攜帶式癌症篩檢設備的市場規模將快速成長，到2030年將達到90.5億美元，複合年成長率（CAGR）為13.1%。預測期內的成長預計將受到以下因素的推動：攜帶式診斷技術投資的增加、人工智慧篩檢平台的日益普及、對分散式醫療服務需求的成長、預防性醫療保健項目的擴展以及先進分子診斷解決方案的進步。預測期內的關鍵趨勢包括：攜帶式癌症篩檢解決方案的普及率提高、對早期癌症檢測技術的需求不斷成長、社區篩檢計畫的擴展、對即時診斷能力的日益重視以及遠端醫療篩檢服務的廣泛應用。

癌症發生率的上升預計將推動攜帶式癌症篩檢設備市場的成長。癌症發生率是指特定族群在特定時期內新確診的癌症病例數。癌症發生率的上升是由人口老化所驅動的。隨著老齡化，基因突變不斷積累，人體修復受損細胞的能力逐漸下降，增加了罹癌風險。攜帶式癌症篩檢設備有助於早期發現癌症，使用簡便，並可實現現場診斷，有助於及時啟動治療，顯著提高患者的預後。例如，根據美國疾病管制與預防中心（CDC）的數據，2022年美國新增癌症病例1,851,238例，2023年有613,349人死於癌症。因此，癌症發生率的上升正在推動攜帶式癌症篩檢設備市場的成長。

行動癌症篩檢設備市場的領導者正致力於開發創新解決方案，例如人工智慧驅動的行動診斷篩檢設備，以實現癌症的早期精準檢測，改善偏遠地區的診斷服務，並提高整體篩檢效率。人工智慧驅動的行動診斷篩檢設備是攜帶式醫療系統，它整合了人工智慧工具，可在現場分析醫療數據，從而在醫療服務匱乏的偏遠地區實現快速、準確的早期疾病篩檢。例如，2026年2月，印度非營利綜合醫療機構卡馬拉·尼赫魯紀念醫院與同樣位於印度的醫療科技新創公司Renek Technologies合作，推出了一個旨在開發用於早期肺癌檢測的人工智慧攜帶式設備的計畫。該計畫旨在透過將人工智慧融入臨床診斷，提高篩檢的速度和準確性，尤其是在早期肺癌的篩檢方面，同時擴大偏遠地區和醫療資源匱乏地區獲得先進診斷服務的機會。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球移動癌症篩檢設備市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 清單：主要原料、資源和供應商
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章：全球市場趨勢與策略

• 關鍵科技與未來趨勢
  • 人工智慧和自主智慧
  • 生物技術、基因組學和精準醫療
  • 物聯網、智慧基礎設施、互聯生態系統
  • 數位化、雲端運算、巨量資料、網路安全
  • 工業4.0和智慧製造
• 主要趨勢
  • 擴大攜帶式癌症篩檢解決方案的應用
  • 對早期癌症檢測技術的需求日益成長
  • 擴大社區篩檢計畫的引入範圍
  • 人們對即時診斷功能越來越感興趣。
  • 擴大遠距遠端醫療篩檢服務

第5章 終端用戶產業市場分析

• 醫院
• 診斷中心
• 行動健康檢查診所
• 門診部
• 其他最終用戶

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球移動癌症篩檢設備市場：PESTEL 分析
• 全球行動癌症篩檢設備市場：規模、對比及成長率分析
• 全球行動癌症篩檢設備市場表現：規模與成長，2020-2025年
• 全球行動癌症篩檢設備市場預測：規模與成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

• 依設備類型
• 醫療影像設備、診斷檢測設備、內視鏡設備、切片檢查設備
• 按癌症類型
• 乳癌、肺癌、大腸癌、子宮頸癌、攝護腺癌、皮膚癌
• 透過技術
• 超音波技術、電腦斷層掃描（CT）技術、磁振造影（MRI）技術、分子診斷技術和基於人工智慧（AI）的篩檢技術。
• 最終用戶
• 醫院、診斷中心、行動健康檢查診所、門診診所、社區醫療保健項目
• 按類型細分：成像設備
• 攜帶式乳房X光攝影系統、移動式電腦斷層掃描器、攜帶式磁振造影造影系統、手持式超音波診斷設備和移動式正子斷層掃描系統。
• 按類型細分：診斷和檢測設備
• 液態生物檢體設備、分子診斷設備、生物標記檢測設備、即時診斷分析儀、癌症檢測套組
• 按類型細分：內視鏡設備
• 攜帶式胃腸內視鏡、移動式支氣管鏡系統、膠囊內視鏡、軟式內視鏡系統、無線內視鏡
• 按類型細分：切片檢查設備
• 針刺切片裝置、真空輔助切片檢查裝置、影像導引切片檢查系統、粗針穿刺切片裝置、細針穿刺切片檢查裝置

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 行動癌症篩檢設備市場：競爭格局及市場佔有率（2024年）
• 移動癌症篩檢設備市場：公司評估矩陣
• 行動癌症篩檢設備市場：公司概況
  • Siemens Healthineers AG
  • GE HealthCare Technologies Inc.
  • Philips Healthcare
  • FUJIFILM Holdings Corporation
  • Hologic Inc.

第37章 其他大型企業和創新企業

• Canon Medical Systems Corporation, Shimadzu Corporation, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Konica Minolta Inc., Samsung Medison Co. Ltd., SonoSite（Fujifilm）, Carestream Health Inc., Neusoft Medical Systems, Esaote SpA, Samsung NeuroLogica, Butterfly Network Inc., Trivitron Healthcare Pvt. Ltd., Planmed Oy, BPL Medical Technologies Private Limited, UE LifeSciences Inc.

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的新創企業

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

• 2030年行動癌症篩檢設備市場：蘊藏新機會的國家
• 2030年行動癌症篩檢設備市場：充滿新機會的細分市場
• 2030年行動癌症篩檢設備市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第42章附錄

Mobile cancer screening devices refer to portable or transportable medical equipment designed to detect early signs of cancer outside of traditional hospital or laboratory settings. These devices enable on-site screening in remote, rural, or underserved areas, improving early diagnosis and access to preventive healthcare services.

The primary device types of mobile cancer screening devices include imaging devices, diagnostic and detection devices, endoscopy devices, and biopsy devices. Imaging devices refer to portable systems used to visualize internal structures of the body for early cancer detection. These devices are used for cancer types including breast cancer, lung cancer, colorectal cancer, cervical cancer, prostate cancer, and skin cancer. They are based on technologies such as ultrasound technology, computed tomography technology, magnetic resonance imaging technology, molecular diagnostics technology, and artificial intelligence-based screening technology and are utilized by end users including hospitals, diagnostic centers, mobile screening clinics, ambulatory care centers, and community healthcare programs.

Tariffs are influencing the mobile cancer screening devices market by increasing the cost of imported imaging components, diagnostic sensors, semiconductor devices, molecular testing materials, and specialized medical equipment used in portable screening systems. This is creating higher manufacturing expenses and supply chain disruptions, leading to increased device costs and delays in deployment activities across healthcare systems. Segments such as imaging devices and diagnostic and detection devices are most affected due to their reliance on advanced imported technologies and precision components. Regions with significant import dependencies, particularly North America, Asia-Pacific, and Europe, are experiencing stronger impacts. However, tariffs are also encouraging local manufacturing expansion, regional supplier diversification, and increased investment in domestic medical device production ecosystems, creating long-term resilience in the market.

The mobile cancer screening devices market size has grown rapidly in recent years. It will grow from $4.88 billion in 2025 to $5.54 billion in 2026 at a compound annual growth rate (CAGR) of 13.5%. The growth in the historic period can be attributed to increasing global cancer prevalence rates, growth in government cancer awareness initiatives, rising demand for early diagnosis programs, expansion of healthcare access in underserved regions, increasing healthcare infrastructure investments.

The mobile cancer screening devices market size is expected to see rapid growth in the next few years. It will grow to $9.05 billion in 2030 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to increasing investment in portable diagnostic technologies, rising adoption of AI based screening platforms, growing demand for decentralized healthcare services, expansion of preventive healthcare programs, increasing development of advanced molecular diagnostic solutions. Major trends in the forecast period include increasing adoption of portable cancer screening solutions, rising demand for early cancer detection technologies, growing deployment of community based screening programs, increasing focus on point of care diagnostic capabilities, expanding use of remote healthcare screening services.

The increasing incidence of cancer is expected to propel the growth of the mobile cancer screening devices market going forward. Cancer incidence refers to the number of new cancer cases diagnosed within a specific population during a certain period. The rising incidence of cancer is driven by an aging population, as advancing age leads to the accumulation of genetic mutations and a gradual decline in the body's ability to repair damaged cells, thereby increasing cancer risk over time. Mobile cancer screening devices support cancer detection by enabling early, accessible, and on-the-spot diagnosis, which improves timely treatment initiation and significantly enhances the chances of better patient outcomes. For instance, in January 2026, according to the Centers for Disease Control and Prevention, a US-based government agency, 1,851,238 new cancer cases were recorded in 2022, and 613,349 deaths due to cancer occurred in 2023. Therefore, the increasing incidence of cancer is driving the growth of the mobile cancer screening devices market.

Major companies operating in the mobile cancer screening devices market are focusing on developing innovative solutions such as AI-enabled mobile diagnostic screening units to enable early and accurate cancer detection, improve diagnostic access in remote areas, and enhance overall screening efficiency. AI-enabled mobile diagnostic screening units are portable healthcare systems integrated with artificial intelligence tools that analyze medical data on-site to enable fast, accurate, and early disease screening in remote or underserved regions. For instance, in February 2026, Kamala Nehru Memorial Hospital, a India-based not-for-profit multi-specialty institution, in collaboration with Lenek Technologies, a India-based health-tech startup, launched a project to develop a portable AI-enabled device for early lung cancer detection. The initiative aims to integrate artificial intelligence with clinical diagnostics to improve the speed and accuracy of lung cancer screening, particularly in early-stage cases, while also expanding access to advanced diagnostic capabilities in remote and resource-limited healthcare settings.

In March 2026, Lord's Mark Industries Limited, an India-based healthcare and medical technology company, partnered with the Centre for Materials for Electronic Technology (CMET), an India-based government research organization specializing in electronic materials and advanced technology development, to develop an AI-based breast cancer detection device. This partnership aims to advance early and accessible breast cancer screening by combining Lord's Mark Industries Limited's expertise in healthcare technology development and commercialization with CMET's capabilities in advanced electronic materials research and sensor technologies. The collaboration focuses on creating a portable, radiation-free screening system that uses AI-driven thermal imaging to detect early abnormalities.

Major companies operating in the mobile cancer screening devices market are Siemens Healthineers AG; GE HealthCare Technologies Inc.; Philips Healthcare; FUJIFILM Holdings Corporation; Hologic Inc.; Canon Medical Systems Corporation; Shimadzu Corporation; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; Konica Minolta Inc.; Samsung Medison Co. Ltd.; SonoSite (Fujifilm); Carestream Health Inc.; Neusoft Medical Systems; Esaote S.p.A.; Samsung NeuroLogica; Butterfly Network Inc.; Trivitron Healthcare Pvt. Ltd.; Planmed Oy; BPL Medical Technologies Private Limited; UE LifeSciences Inc.; Niramai Health Analytix Private Limited; Forward Science LLC

North America was the largest region in the mobile cancer screening devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mobile cancer screening devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the mobile cancer screening devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mobile cancer screening devices market consists of revenues earned by entities by providing services such as on-site cancer screening services, mobile diagnostic imaging services, early detection and screening program management services, tele-diagnostic and remote reporting services, and equipment leasing and maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The mobile cancer screening devices market also includes sales of sample collection kits, liquid biopsy assay kits, molecular diagnostic reagents, and sample preservation and transport media kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The mobile cancer screening devices market research report is one of a series of new reports from The Business Research Company that provides mobile cancer screening devices market statistics, including mobile cancer screening devices industry global market size, regional shares, competitors with a mobile cancer screening devices market share, detailed mobile cancer screening devices market segments, market trends and opportunities, and any further data you may need to thrive in the mobile cancer screening devices industry. This mobile cancer screening devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Mobile Cancer Screening Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses mobile cancer screening devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mobile cancer screening devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mobile cancer screening devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Device Type: Imaging Devices; Diagnostic And Detection Devices; Endoscopy Devices; Biopsy Devices
• 2) By Cancer Type: Breast Cancer; Lung Cancer; Colorectal Cancer; Cervical Cancer; Prostate Cancer; Skin Cancer
• 3) By Technology: Ultrasound Technology; Computed Tomography Technology; Magnetic Resonance Imaging Technology; Molecular Diagnostics Technology; Artificial Intelligence Based Screening Technology
• 4) By End User: Hospitals; Diagnostic Centers; Mobile Screening Clinics; Ambulatory Care Centers; Community Healthcare Programs
• Subsegments:
• 1) By Imaging Devices: Portable Mammography Systems; Mobile Computed Tomography Scanners; Portable Magnetic Resonance Imaging Systems; Handheld Ultrasound Devices; Mobile Positron Emission Tomography Systems
• 2) By Diagnostic And Detection Devices: Liquid Biopsy Devices; Molecular Diagnostic Devices; Biomarker Detection Devices; Point Of Care Diagnostic Analyzers; Cancer Screening Test Kits
• 3) By Endoscopy Devices: Portable Gastrointestinal Endoscopy Devices; Mobile Bronchoscopy Systems; Capsule Endoscopy Devices; Flexible Endoscopy Systems; Wireless Endoscopy Devices
• 4) By Biopsy Devices: Needle Biopsy Devices; Vacuum Assisted Biopsy Devices; Image Guided Biopsy Systems; Core Needle Biopsy Devices; Fine Needle Aspiration Devices
• Companies Mentioned: Siemens Healthineers AG; GE HealthCare Technologies Inc.; Philips Healthcare; FUJIFILM Holdings Corporation; Hologic Inc.; Canon Medical Systems Corporation; Shimadzu Corporation; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; Konica Minolta Inc.; Samsung Medison Co. Ltd.; SonoSite (Fujifilm); Carestream Health Inc.; Neusoft Medical Systems; Esaote S.p.A.; Samsung NeuroLogica; Butterfly Network Inc.; Trivitron Healthcare Pvt. Ltd.; Planmed Oy; BPL Medical Technologies Private Limited; UE LifeSciences Inc.; Niramai Health Analytix Private Limited; Forward Science LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Mobile Cancer Screening Devices Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Mobile Cancer Screening Devices Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Mobile Cancer Screening Devices Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Mobile Cancer Screening Devices Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Biotechnology, Genomics & Precision Medicine
  • 4.1.3 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.5 Industry 4.0 & Intelligent Manufacturing
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Portable Cancer Screening Solutions
  • 4.2.2 Rising Demand For Early Cancer Detection Technologies
  • 4.2.3 Growing Deployment Of Community Based Screening Programs
  • 4.2.4 Increasing Focus On Point Of Care Diagnostic Capabilities
  • 4.2.5 Expanding Use Of Remote Healthcare Screening Services

5. Mobile Cancer Screening Devices Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Diagnostic Centers
• 5.3 Mobile Screening Clinics
• 5.4 Ambulatory Care Centers
• 5.5 Other End Users

6. Mobile Cancer Screening Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Mobile Cancer Screening Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Mobile Cancer Screening Devices PESTEL Analysis (Political, Economical, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Mobile Cancer Screening Devices Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Mobile Cancer Screening Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Mobile Cancer Screening Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Mobile Cancer Screening Devices Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Mobile Cancer Screening Devices Market Segmentation

• 9.1. Global Mobile Cancer Screening Devices Market, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Imaging Devices, Diagnostic And Detection Devices, Endoscopy Devices, Biopsy Devices
• 9.2. Global Mobile Cancer Screening Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, Prostate Cancer, Skin Cancer
• 9.3. Global Mobile Cancer Screening Devices Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Ultrasound Technology, Computed Tomography Technology, Magnetic Resonance Imaging Technology, Molecular Diagnostics Technology, Artificial Intelligence Based Screening Technology
• 9.4. Global Mobile Cancer Screening Devices Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Diagnostic Centers, Mobile Screening Clinics, Ambulatory Care Centers, Community Healthcare Programs
• 9.5. Global Mobile Cancer Screening Devices Market, Sub-Segmentation Of Imaging Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Portable Mammography Systems, Mobile Computed Tomography Scanners, Portable Magnetic Resonance Imaging Systems, Handheld Ultrasound Devices, Mobile Positron Emission Tomography Systems
• 9.6. Global Mobile Cancer Screening Devices Market, Sub-Segmentation Of Diagnostic And Detection Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Liquid Biopsy Devices, Molecular Diagnostic Devices, Biomarker Detection Devices, Point Of Care Diagnostic Analyzers, Cancer Screening Test Kits
• 9.7. Global Mobile Cancer Screening Devices Market, Sub-Segmentation Of Endoscopy Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Portable Gastrointestinal Endoscopy Devices, Mobile Bronchoscopy Systems, Capsule Endoscopy Devices, Flexible Endoscopy Systems, Wireless Endoscopy Devices
• 9.8. Global Mobile Cancer Screening Devices Market, Sub-Segmentation Of Biopsy Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Needle Biopsy Devices, Vacuum Assisted Biopsy Devices, Image Guided Biopsy Systems, Core Needle Biopsy Devices, Fine Needle Aspiration Devices

10. Mobile Cancer Screening Devices Market Regional And Country Analysis

• 10.1. Global Mobile Cancer Screening Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Mobile Cancer Screening Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Mobile Cancer Screening Devices Market

• 11.1. Asia-Pacific Mobile Cancer Screening Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Mobile Cancer Screening Devices Market, Segmentation By Device Type, Segmentation By Cancer Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Mobile Cancer Screening Devices Market

• 12.1. China Mobile Cancer Screening Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Mobile Cancer Screening Devices Market, Segmentation By Device Type, Segmentation By Cancer Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Mobile Cancer Screening Devices Market

• 13.1. India Mobile Cancer Screening Devices Market, Segmentation By Device Type, Segmentation By Cancer Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Mobile Cancer Screening Devices Market

• 14.1. Japan Mobile Cancer Screening Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Mobile Cancer Screening Devices Market, Segmentation By Device Type, Segmentation By Cancer Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Mobile Cancer Screening Devices Market

• 15.1. Australia Mobile Cancer Screening Devices Market, Segmentation By Device Type, Segmentation By Cancer Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Mobile Cancer Screening Devices Market

• 16.1. Indonesia Mobile Cancer Screening Devices Market, Segmentation By Device Type, Segmentation By Cancer Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Mobile Cancer Screening Devices Market

• 17.1. South Korea Mobile Cancer Screening Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Mobile Cancer Screening Devices Market, Segmentation By Device Type, Segmentation By Cancer Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Mobile Cancer Screening Devices Market

• 18.1. Taiwan Mobile Cancer Screening Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Mobile Cancer Screening Devices Market, Segmentation By Device Type, Segmentation By Cancer Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Mobile Cancer Screening Devices Market

• 19.1. South East Asia Mobile Cancer Screening Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Mobile Cancer Screening Devices Market, Segmentation By Device Type, Segmentation By Cancer Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Mobile Cancer Screening Devices Market

• 20.1. Western Europe Mobile Cancer Screening Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Mobile Cancer Screening Devices Market, Segmentation By Device Type, Segmentation By Cancer Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Mobile Cancer Screening Devices Market

• 21.1. UK Mobile Cancer Screening Devices Market, Segmentation By Device Type, Segmentation By Cancer Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Mobile Cancer Screening Devices Market

• 22.1. Germany Mobile Cancer Screening Devices Market, Segmentation By Device Type, Segmentation By Cancer Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Mobile Cancer Screening Devices Market

• 23.1. France Mobile Cancer Screening Devices Market, Segmentation By Device Type, Segmentation By Cancer Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Mobile Cancer Screening Devices Market

• 24.1. Italy Mobile Cancer Screening Devices Market, Segmentation By Device Type, Segmentation By Cancer Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Mobile Cancer Screening Devices Market

• 25.1. Spain Mobile Cancer Screening Devices Market, Segmentation By Device Type, Segmentation By Cancer Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Mobile Cancer Screening Devices Market

• 26.1. Eastern Europe Mobile Cancer Screening Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Mobile Cancer Screening Devices Market, Segmentation By Device Type, Segmentation By Cancer Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Mobile Cancer Screening Devices Market

• 27.1. Russia Mobile Cancer Screening Devices Market, Segmentation By Device Type, Segmentation By Cancer Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Mobile Cancer Screening Devices Market

• 28.1. North America Mobile Cancer Screening Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Mobile Cancer Screening Devices Market, Segmentation By Device Type, Segmentation By Cancer Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Mobile Cancer Screening Devices Market

• 29.1. USA Mobile Cancer Screening Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Mobile Cancer Screening Devices Market, Segmentation By Device Type, Segmentation By Cancer Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Mobile Cancer Screening Devices Market

• 30.1. Canada Mobile Cancer Screening Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Mobile Cancer Screening Devices Market, Segmentation By Device Type, Segmentation By Cancer Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Mobile Cancer Screening Devices Market

• 31.1. South America Mobile Cancer Screening Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Mobile Cancer Screening Devices Market, Segmentation By Device Type, Segmentation By Cancer Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Mobile Cancer Screening Devices Market

• 32.1. Brazil Mobile Cancer Screening Devices Market, Segmentation By Device Type, Segmentation By Cancer Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Mobile Cancer Screening Devices Market

• 33.1. Middle East Mobile Cancer Screening Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Mobile Cancer Screening Devices Market, Segmentation By Device Type, Segmentation By Cancer Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Mobile Cancer Screening Devices Market

• 34.1. Africa Mobile Cancer Screening Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Mobile Cancer Screening Devices Market, Segmentation By Device Type, Segmentation By Cancer Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Mobile Cancer Screening Devices Market Regulatory and Investment Landscape

36. Mobile Cancer Screening Devices Market Competitive Landscape And Company Profiles

• 36.1. Mobile Cancer Screening Devices Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Mobile Cancer Screening Devices Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Mobile Cancer Screening Devices Market Company Profiles
  • 36.3.1. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. FUJIFILM Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Mobile Cancer Screening Devices Market Other Major And Innovative Companies

• Canon Medical Systems Corporation, Shimadzu Corporation, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Konica Minolta Inc., Samsung Medison Co. Ltd., SonoSite (Fujifilm), Carestream Health Inc., Neusoft Medical Systems, Esaote S.p.A., Samsung NeuroLogica, Butterfly Network Inc., Trivitron Healthcare Pvt. Ltd., Planmed Oy, BPL Medical Technologies Private Limited, UE LifeSciences Inc.

38. Global Mobile Cancer Screening Devices Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Mobile Cancer Screening Devices Market

41. Mobile Cancer Screening Devices Market High Potential Countries, Segments and Strategies

• 41.1 Mobile Cancer Screening Devices Market In 2030 - Countries Offering Most New Opportunities
• 41.2 Mobile Cancer Screening Devices Market In 2030 - Segments Offering Most New Opportunities
• 41.3 Mobile Cancer Screening Devices Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer